<bill session="117" type="h" number="7035" updated="2023-03-08T19:58:48Z">
  <state datetime="2022-03-09">REFERRED</state>
  <status>
    <introduced datetime="2022-03-09"/>
  </status>
  <introduced datetime="2022-03-09"/>
  <titles>
    <title type="display">Biologics Market Transparency Act of 2022</title>
    <title type="short" as="introduced">Biologics Market Transparency Act of 2022</title>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act to require prompt reports of marketing status by holders of approved applications for biological products, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="M001135"/>
  <cosponsors>
    <cosponsor bioguide_id="H001067" joined="2022-03-09"/>
  </cosponsors>
  <actions>
    <action datetime="2022-03-09">
      <text>Introduced in House</text>
    </action>
    <action datetime="2022-03-09" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2022-03-10">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="117" type="h" number="7667" relation="unknown"/>
    <bill session="117" type="s" number="4348" relation="unknown"/>
    <bill session="117" type="s" number="4302" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2022-10-18T14:43:13Z" status="Introduced in House">Biologics Market Transparency Act of 2022

This bill requires biologics manufacturers to notify the Food and Drug Administration in advance of withdrawing a product from sale.</summary>
</bill>
